Home > About us > R & D
- R & D
- We have been developing various ranges of pharmaceutical technologies specially focusing on Bio-pharmaceuticals such as recombinant proteins, synthetic peptides, and DDS bio similar based on three kinds of platform technologies of E.coli culture, mammalian cell culture, and peptide synthesis & formulation
As a result of our enthusiastic efforts and investments, we have already successfully commercialized bio-similar products such as PEG IFN alpha, EPO, hGH, etc., by using gene recombinant technology and have been preparing PEG-EPO, PEG-GCSF, mAbs and peptide drugs by using DDS technology.
